NDC product
Loperamide Hydrochloride
NDC 68016-123 · Chain Drug Consortium, LLC
Key facts
| Product NDC | 68016-123 |
|---|---|
| Proprietary name | Loperamide Hydrochloride |
| Nonproprietary name | Loperamide Hydrochloride |
| Substances | LOPERAMIDE HYDROCHLORIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Chain Drug Consortium, LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA074091 |
| Pharmacologic classes | Opioid Agonist [EPC], Opioid Agonists [MoA] |
| Marketing start | Feb 1, 1993 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: